# Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)

> **NCT02180451** · — · UNKNOWN · sponsor: **Vanda Pharmaceuticals** · enrollment: 8 (actual)

## Conditions studied

- Smith Magenis Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02180451
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180451, "Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02180451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*